In recent years, metallic nanoparticles have attracted tremendous attention in nanomedicine. Here, we report green synthesis and determination of silver chloride nanoparticles synthesized using Artemisia sieberi extract (AgClNPs-ASE) and its anticancer properties against human breast cancer cells. Numerous techniques, such as X-ray diffraction (XRD), UV-visible spectra, transmission electron microscopy (TEM), scanning electron microscopy-energy dispersive spectra (SEM–EDS), and dynamic light scattering (DLS) analysis determined the morphology characteristics and size of the obtained nanoparticles. Cytotoxic properties of AgClNPs-ASE were carried out toward human breast cancer MDA-MB-231 cells and nontumorigenic HEK293 cells. AgClNPs-ASE revealed better efficacy toward breast cancer cells and was relatively less cytotoxic to nontumorigenic cells. Induction of apoptosis was further revealed by Hoechst 33258 dye and dual acridine orange and ethidium bromide (AO/EB) staining and in cells along with upregulation of caspase-8 and 9 proteins. AgClNPs-ASE could trigger the apoptosis by upregulation of early (1.93%) and late (58.86%) apoptosis followed by fluorescein isothiocyanate (FITC)‐Annexin‐V/PI staining and enhanced cell cycle population (sub-G1). AgClNPs-ASE significantly increased NO production in cancer cells. Moreover, qRT-PCR study showed that AgClNPs-ASE treated cells induce increased expression of the LncRNA GAS5 gene. These findings suggest the remarkable apoptosis in cancer cells triggered by AgClNPs-ASE in vitro.